Acromegaly Presenting as Hypogonadism
UCLA Department of Medicine Clinical Insights · 10.07.2026 · 1 (2)
DOI: 10.5070/v6.64096 ↗Kurz gefasst
Fachartikel in der Zeitschrift UCLA Department of Medicine Clinical Insights, online erschienen am 10.07.2026. Verfasst von Aarthi Arasu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acromegaly is a rare endocrine disorder caused by excess growth hormone (GH), most commonly from a pituitary adenoma. Diagnosis is frequently delayed due to insidious onset and subtle clinical manifestations. We report a 37-year-old male who presented with fatigue and weight gain, initially prompting evaluation for hypogonadism. Laboratory testing revealed low testosterone and mild hyperprolactinemia, leading to a broader pituitary evaluation. Insulin-like growth factor-1 (IGF-1) was elevated on repeated testing, and GH failed to suppress during oral glucose tolerance testing, confirming acromegaly. Pituitary MRI demonstrated a 9 mm sellar lesion. The patient underwent transnasal transsphenoidal surgery with gross total resection. Pathology confirmed a GH-secreting adenoma. Postoperative GH levels were consistent with biochemical remission. This case highlights the importance of considering acromegaly in patients with nonspecific symptoms and minimal physical findings.
Zitieren
APA
Arasu, A., & Bose, V. (2026). Acromegaly Presenting as Hypogonadism. UCLA Department of Medicine Clinical Insights, 1(2). https://doi.org/10.5070/v6.64096
Vancouver
Arasu A, Bose V. Acromegaly Presenting as Hypogonadism. UCLA Department of Medicine Clinical Insights. 2026;1(2). doi:10.5070/v6.64096
BibTeX
@article{Arasu2026,
author = {Arasu, Aarthi and Bose, Vivek},
title = {Acromegaly Presenting as Hypogonadism},
journal = {UCLA Department of Medicine Clinical Insights},
year = {2026},
volume = {1},
number = {2},
doi = {10.5070/v6.64096}
}
EUVIMED